Generic Formulations
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
5,950
NCT06627322
A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
Phase: N/A
Role: Collaborator
Start: Nov 21, 2024
Completion: Sep 30, 2029
Loading map...